
Veracyte Advances Urologic Cancer Care With Robust Data at 2026 ASCO GU Symposium
Veracyte Showcases Over 15 Abstracts Highlighting Decipher and TrueMRD Genomic Tests What if genomic tests could revolutionize the way we treat urologic cancers? Veracyte, Inc. a leading cancer diagnostics company,…












